Cancer treatment

Herpes virus cells
#Cancer research #Cancer treatment #Herpes virus #Immunotherapy #Oncology #The Institute of Cancer Research

Researchers successfully exploit virus against advanced cancers

A new genetically engineered herpes virus has delivered a one-two punch against advanced cancers in initial findings from a Phase I trial. Researchers have found that RP2 – a modified version of the herpes simplex virus – showed signs of effectiveness in a quarter of patients with a range of… Read More

#Cancer Research #News #Trending News

Small cell lung cancer
#Cancer research #Cancer treatment #Lung cancer

Combination therapy halts lung cancer tumour growth in mice

An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a recent study. The discovery was made by researchers at Washington University School of Medicine in St Louis, Grenoble Alpes University in Grenoble in France, and The University… Read More

#Cancer Research #News

Natural killer cells
#allogeneic cell therapies #Cancer immunotherapy #Cancer research #Cancer treatment

Zelluna Immunotherapy secures funding for cancer treatments

Investment from Takeda ventures will fund the development of Zelluna Immunotherapy’s allogeneic T Cell Receptor Natural Killer (TCR-NK) cells for the treatment of cancer. The funds will enable the advancement of a lead TCR-NK product through manufacturing to Clinical Trial Application (CTA) / Investigational New Drug Application (IND) readiness and,… Read More

#Business & Investment #Cancer Research #News